In The News
Cincinnati Edition
Jeffrey S. Crowley
In The News
DW
Jeffrey S. Crowley
‘Miracle’ HIV drug lenacapavir approved amid US budget cuts
In The News
Infectious Disease Special Edition
Jeffrey S. Crowley
What Fate Awaits U.S. HIV Research and Programs?
In The News
PBS
Statement
Jeffrey S. Crowley Matthew M. Kavanagh Charles Holmes
O’Neill’s Crowley, Kavanagh, and Holmes on FDA’s Approval of Lenacapavir for HIV Prevention
In The News
UNAIDS
Matthew M. Kavanagh
Global health leaders: Pandemic Agreement can help fight inequalities and AIDS
Press Release
In The News
Positively Aware
Statement
Michele Goodwin Lawrence O. Gostin Jeffrey S. Crowley
Statement from Leaders at the O’Neill Institute for National and Global Health Law on Plans to Eliminate the CDC’s Division of HIV Prevention
In The News
POZ
Jeffrey S. Crowley Kirk Grisham
How to Improve Safety and HIV Care for Trans and Gender-Nonconforming People
In The News
Health Policy Watch
In The News
NPR
Matthew M. Kavanagh
Trump’s ‘stop-work’ order for PEPFAR cuts off anti-HIV drugs for patients
In The News
Nation
Matthew M. Kavanagh
Injectable ARVs: The new technology in the fight against HIV and AIDS
In The News
Black Health Matters
Jeffrey S. Crowley
Medicaid Should Make Longer Acting HIV Medication Accessible
Statement
Kirk Grisham Jeffrey S. Crowley
O’Neill Institute’s Experts on Results of PURPOSE 2 HIV Prevention Study
In The News
Scripps News
Jeffrey S. Crowley
Scripps News Reports: The Cure for HIV
In The News
Managed Healthcare Executive
Jeffrey S. Crowley Kirk Grisham
Medicaid Must Make Crucial Changes to Get Ahead of the HIV Epidemic
In The News
POZ
Jeffrey S. Crowley Kirk Grisham
Medicaid Urged to Ensure Access to Long-Acting Meds That Treat and Prevent HIV
Press Release
Matthew M. Kavanagh Alana Sharp
Collaborative Study on Community Engagement in Country Coordinating Mechanisms Wins 2024 Robert Carr Research Award
In The News
Managed Healthcare Executive
Lawrence O. Gostin
Now is Not the Time to End the Global AIDS Effort | AIDS 2024
Press Release
Statement
Charles Holmes Kirk Grisham
O’Neill Institute’s Experts on Results of PURPOSE 1 HIV Prevention Study
Statement
In The News
Los Angeles Times
Sonia L. Canzater